Xi Chen
Founder of RootPath
West Newton, Massachusetts
Overview
Work Experience
Founder
2017 - Current
We enable biology at scale.
RootPath Genomics is a biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine.
Raised $68,000,000.00 from Sky9 Capital, Matrix Partners China, CDH Investments and Hony Capital.
Team Member
2016 - 2017
Early-stage biotech investment and venture creation.
R&D Scientist
2015 - 2016
Ultivue is a biotechnology company that specializes in tissue imaging, diagnostics, and multiplexing.
Raised $110,576,238.00 from Northpond Ventures, Applied Ventures, Tao Capital Partners, Ally Bridge Group, Pura Vida Investments and ARCH Venture Partners.
Jane Coffin Childs Postdoctoral Fellow
2012 - 2015
Worked in the lab of Dr. Peng Yin on the application of DNA circuitry in early cancer detection.
CPRIT Postdoctoral Fellow
2011 - 2012
Led a research group within the Ellington Lab to tackle theoretical and practical problems in applying DNA circuitry to molecular diagnostics and synthetic biology.